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Abstract
Introduction: It is difficult to adjust fluid balance adequately in patients with severe burns due to various physical
changes. B-type natriuretic peptide (BNP) is emerging as a potential marker of hydration state. Proteinuria is used
as a predictor of outcome in severe illness and might correlate to systemic capillary leakage. This study investigates
whether combining BNP and proteinuria can be used as a guide for individualized resuscitation and as a predictor
of outcome in patients with severe burns.
Methods: From 2006 to 2009, 38 consecutive patients (age 47 ± 15 years, 74% male) with severe burns were
included and followed for 20 days. All had normal kidney function at admission. BNP and proteinuria were
routinely measured. Ordered and actually administered fluid resuscitation volumes were recorded. The Sequential
Organ Failure Assessment (SOFA) score was used as the measure of outcome.
Results: BNP increased during follow-up, reaching a plateau level at Day 3. Based on median BNP levels at Day 3,
patients were divided into those with low BNP and those with high BNP levels. Both groups had comparable initial
SOFA scores. Patients with high BNP received less fluid from Days 3 to 10. Furthermore, patients with a high BNP
at Day 3 had less morbidity, reflected by lower SOFA scores on the following days. To minimize effects of
biological variability, proteinuria on Days 1 and 2 was averaged. By dividing the patients based on median BNP at
Day 3 and median proteinuria, patients with high BNP and low proteinuria had significantly lower SOFA scores
during the entire follow-up period compared to those patients with low BNP and high proteinuria.
Conclusions: Patients with higher BNP levels received less fluid. This might be explained by a lower capillary
leakage in these patients, resulting in more intravascular fluid and consequently an increase in BNP. In combination
with low proteinuria, possibly reflecting minimal systemic capillary leakage, a high BNP level was associated with a
better outcome. BNP and proteinuria have prognostic potential in severely burned patients and may be used to
adjust individual resuscitation.
Introduction
An important feature of burn trauma is a massive loss
of plasma from the intravascular to the extravascular
space due to systemic microvascular leakage, which is
triggered by inflammatory mediators [1]. Capillary
leakage is massive during the first 12 to 16 hours, and
then decreases. Because of this capillary leakage and
vasodilatation in combination with alterations in cardiac
function, it is difficult to maintain, monitor and adjust
fluid balance in patients with severe burns [2].
Fluid resuscitation is vital in severely burned patients.
Yet, resuscitation with too large volumes of fluid has sev-
eral negative consequences, including compartment syn-
dromes, conversion of superficial burns into deep burns
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plications can occur, such as pulmonary edema and intra-
abdominal hypertension. Current markers of adequacy of
resuscitation are normalization of serum lactate, urine
production or invasive measurements [3]. However, clear-
ance of serum lactate depends on adequate liver function,
adequate renal function, and normal electrolyte levels.
Furthermore, Papp et al. demonstrated that serum lactate
as well as urine production could be normal despite the
presence of hypovolaemia as measured by central venous
pressure and pulmonary artery wedge pressure [4]. These
last measurements might be the gold standard to deter-
mine hemodynamics; however, these measurements are
invasive and not performed regularly in every hospital.
Because of these limitations of the current markers to
monitor resuscitation, other biomarkers, specifically mar-
kers that can be measured at the bedside, are needed.
An interesting marker might be serum B-type
natriuretic peptide (BNP). BNP is secreted from myocar-
dium under increased wall stretch and is used as a non-
invasive method to detect heart failure [5-8]. Recently,
Friese et al. showed an increase of BNP levels after
resuscitation in trauma patients, suggesting it might be
a marker of volume resuscitation after injury [3].
Increase of BNP levels during the first 72 hours of
resuscitation has also been demonstrated in nine burn
patients [4]. It can be hypothesized that an absence in
increase of BNP levels, reflecting no increase in ventri-
cular pressure, in severely burned patients despite high
amounts of fluids indicates an inadequate resuscitation.
The explanation of no increase in ventricular pressure
might be the ongoing increased capillary leakage, caus-
ing a persistent low intravascular volume.
It would even be better to find a marker which reflects
the massive capillary leakage present in patients with
burns. Capillary leakage is one of the events in endothe-
lial dysfunction [9]. Proteinuria, especially microalbumi-
nuria, is believed to reflect endothelial dysfunction even
in otherwise healthy persons [10-12]. Proteinuria thus
might be useful as a indirect marker of systemic capil-
lary leakage. Moreover, it also has been associated with
illness severity and mortality on the intensive care unit,
thus having a prognostic potential [13,14].
Based on these findings, we hypothesize that low
levels of BNP in combination with increased levels of
proteinuria reflect inadequate resuscitation due to
increased capillary leakage and predict worse outcome
in patients with severe burns.
Methods and methods
Patients
Between January 2006 and October 2009, all consecutive
patients admitted to the burn centre of the Martini Hos-
pital were included. Inclu s i o nc r i t e r i aw e r eat o t a l
burned body surface area (TBSA) ≥ 20% or TBSA
between 15 and 20% and inhalation injury. Exclusion
criteria were age < 18 years and a life expectancy less
than 24 hours.
In total 38 patients were included. Main characteris-
tics at admission are presented in Table 1.
All clinical data were collected prospectively on a daily
basis. The local research ethics committees gave
approval for the study. Informed consent was not
deemed necessary.
Data collection
Retrospective analyses of a prospectively collected data-
base were performed. Data were collected from the day
of admission until Day 20 post-burn. At the day of
admission the following variables were recorded: gender,
Table 1 Characteristics at admission
Patients (n = 38) Patients with low BNP (n = 19) Patients with high BNP (n = 19)
Age, years 45 (37 to 60) 46 (31 to 59) 47 (37 to 63)
Male, n (%) 28 (74%) 15 (79%) 13 (68%)
Weight, kg 87 (74 to 100) 90 (77 to 112) 85 (70 to 99)
Medical history, n (%)
No CVD, DM or hypertension 29 (76%) 14 (74%) 15 (79%)
CVD, DM and/or hypertension 9 (24%) 5 (26%) 4 (21%)
Patients with CVD 5 (13%) 3 (16%) 2 (11%)
TBSA > 20%, n (%) 33 (87%) 17 (89%) 16 (84%)
15 with inhalation 9 with inhalation 6 with inhalation
TBSA 15 to 20% and inhalation, n (%) 5 (13%) 2 (11%) 3 (16%)
Intubation, n (%) 29 (76%) 14 (74%) 15 (79%)
TBSA, % 32 (24 to 42) 35 (24 to 41) 28 (20 to 43)
Full thickness burn, % 15 (8 to 25) 17 (8 to 32) 13 (5 to 23)
Creatinin clearance, ml/min 139 (88 to 190) 149 (122 to 193) 109 (81 to 192)
Data are presented by median (interquartile range).
CVD, cardiovascular disease; DM, diabetes mellitus; TBSA, total burned body surface area.
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thickness burn, presence of inhalation injury and intuba-
tion, trauma mechanism, comorbidity and use of RAAS-
inhibitors. Furthermore, at admission and every day at
6.00 am. vital signs (blood pressure and heart rate) were
measured. Blood was drawn for several measurements,
including BNP which was measured with a two-step
chemiluminescent microparticle immunoassay (CMIA)
in human EDTA plasma on the ARCHITECT 2000i Sys-
tem (ABBOTT Diagnostic Division; decision threshold
for heart failure 100 ng/l); detection limit ≤ 10 ng/l;
measurement range 10 to 5,000 ng/l; Total analytical
CV at 92.2 ng/l is 4.4%, at 504.3 is 2.7%. As BNP levels
increased in the first days of admission and reached a
plateau at Day 3 post-burn, patients were divided based
on median of BNP level at Day 3.
Urine output was recorded and collected to analyse
proteinuria, which was measured with a Microprotein
Assay (pyrogallol red and molybdate method) on de
SYNCHRON LX20 (Beckman Coulter); reference range
< 0.14 g/l; detection limit is 0.06 g/l; measurement
range 0.06 to 1.50 g/l; Total analytical CV at 0.17 g/l is
3.8% and at 0.67 g/l is 3.7%. Because of high variability,
proteinuria on Days 1 and 2 was averaged.
Every day, dosage and type of catecholamines, the
fraction of oxygen in inspired gas and the amount of
fluids ordered and actually given were noted. The
amount of fluids in the first 48 hours was determined
based on the following formulas: from 0 to 8 hours 1.5
ml × weight (kg) × TBSA (%) + 800 ml; from 8 to 24
hours 1 ml × weight (kg) × TBSA (%) + 1,600; from 24
to 48 hours, 1 ml × weight (kg) × TBSA (%) + 3,600 ml.
After the first 48 hours, the amount of fluid is corrected
based on a minimum urine production of 0.5 ml ×
weight (kg)/hour. The ordered volumes and the actually
received volumes were recorded.
The mean outcome of survival was assessed by the
Sequential Organ Failure Assessment (SOFA) score [15].
However, a good clinical condition of a patient has lead
to a decrease in frequency of measurements necessary
to determine SOFA score. In patients with good clinical
condition, interpolated values based on the most recent
and subsequent recorded values were used to calculate
SOFA-scores.
Statistical methods
In this small group of patients all variables were not-
normally distributed (Shapiro-Wilk test P-values < 0.05),
except for age. We decided to report all data as median
and interquartile range.
Comparisons between the different groups of patients
were made by Mann-Whitney tests for continuous vari-
ables and by chi-square analysis for categorical variables.
Patients were divided based on median of BNP at Day
3 post-burn (118 ng/l) and median of the averaged pro-
t e i n u r i aa tD a y s1a n d2( 0 . 9g / 2 4h r ) .T h eu n i v a r i a t e
correlation between BNP at Day 3 or averaged protei-
nuria at Days 1 and 2 and other categorical variables
was assessed by Pearson correlation coefficient. Multi-
ple-linear regression analyses were undertaken to deter-
mine contributions to BNP levels at Day 3. Potential
predictor variables included gender, age, renal function,
cardiac disease, total intravenous fluid therapy of day of
injury until Day 2, inhalation injury and TBSA. A back-
wards elimination procedure was used to discard predic-
tor variables with P < 0.1 in multiple regression models
one by one until a final ‘best’ model was achieved.
Analyses were performed with SPSS, version 15.0 for
Windows (SPSS Inc., Chicago, IL, USA). In addition, we
conducted Latent Growth Modeling with MPlus version
6.1 to analyse the influence of time between groups
[16]. An alpha of 5% was adopted. Bonferroni-Holm
corrections were used for multiple testing of hypotheses.
Results
B-type natriuretic peptide
Median BNP was 24 (8 to 88) ng/l on day of admission
a n d3 3( 1 8t o7 2 )n g / lo nD a y1p o s t - b u r n .B N P
increased significantly during the following days. At
D a y3p o s t - b u r n ,ap l a t e a ul e v e lo fB N Pw a sr e a c h e d
(Figure 1).
B a s e do nm e d i a nB N Pl e v e la tD a y3p o s t - b u r n ,
patients were divided in those with low BNP and those
with high BNP levels. Baseline characteristics did not
differ between the two groups (Table 1). For patients
with high BNP levels, less fluid volumes were ordered at
d a y s3 ,4a n d5( P < 0.05). Received fluid volumes also
were less from Day 3 to Day 10 (P < 0.05).
Levels of BNP at Day 3 post-burn were negatively cor-
related to the amounts of received fluids at days 4, 5, 6,
17 and 20 (r = -0.46, -0.39, -0.49, -0.39 and -0.47
Figure 1 B-type Natriuretic Peptide (BNP) levels during follow
up. This figure demonstrates the BNP levels during follow-up. A
plateau level is reached at Day 3.
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correction). Levels of BNP were negatively correlated to
SOFA scores at days 16, 18 and 20 (r = -0.45, -0.54 and
-0.42 respectively, all with P <0 . 0 5w i t hB o n f e r r o n i -
Holm correction). Furthermore, patients with a high
BNP levels had less morbidity, reflected by lower SOFA
scores (Figure 2).
In univariate analysis, no correlations were found
between levels of BNP with age (r = 0.28, P = 0.13),
TBSA (r = -0.25, P = 0.17), weight (r = -0.20, P =0 . 2 7 ) ,
creatinin clearance (r = -0.23, P = 0.27), urine produc-
tion (r = 0.27, P = 0.14) or heart rate (r = -0.20, P =
0.27). Furthermore, levels of BNP did not differ between
gender (female vs male, 199 (101 to 402) ng/l vs 114 (36
to 200) ng/l, P = 0.35). BNP levels tended to be lower in
patients with inhalation injury (106 (30 to 178) ng/l, n =
18 versus 225 (104 to 385) ng/l, n = 20, P = 0.053).
Multiple-linear regression analyses were performed to
determine contributions to BNP levels at Day 3. Poten-
tial predictor variables included gender, age, renal func-
tion, cardiac disease, total intravenous fluid therapy of
day of injury until Day 2, inhalation injury and TBSA.
Backward elimination procedure revealed that age, inha-
lation injury and total fluid therapy until Day 2 were the
most important determinants of BNP levels at Day 3 (R
square = 0.81, beta = 0.44, P = 0.02, beta = -0.510, P =
0.02, and beta = -0.37, P = 0.07, respectively).
Latent Growth Modelling showed no difference in
initial SOFA scores for the groups with high or low
BNP at Day 3 (predictive posterior P-value = .36). The
high BNP group is reaching better SOFA scores earlier
(regression weight for slope difference is -0.22 per day,
P = .03, one-tailed).
Proteinuria
Because of expected high variability, proteinuria on
Days 1 and 2 was averaged (median 0.91 (0.59 to 2.75)
g/24 hr). Averaged proteinuria on Days 1 and 2 was
positively correlated to SOFA score at Days 0, 1 and 2
(r = 0.35, 0.47 and 0.45 respectively, all with P <0 . 0 5
with Bonferroni-Holm corrections). No correlations
were found between levels of averaged proteinuria
with age, TBSA, weight and creatinin clearance. Pro-
teinuria tended to be higher in patients with inhala-
tion injury (1.74 (0.63 to 4.96) g/24 hr, n =2 0 ,v e r s u s
0.64 (0.5 to 1.07) g/24 hr, n =1 8 ,P = 0.08). Latent
Growth Modeling showed differences in initial SOFA
scores for the groups with high or low proteinuria.
The SOFA score of the high proteinuria group was on
average 2.2 points higher (posterior predictive P-value
= < .0001). The effect of time was in both groups
equal (P = .225)
Combining BNP and proteinuria
By dividing all patients based on the median of BNP
level at Day 3 and the median of averaged proteinuria at
Days 1 and 2, the four different groups did not differ in
age, TBSA, inhalation trauma, use of RAAS-inhibitors
or number of deceased patients (Table 2). Patients with
high BNP and low proteinuria had significantly lower
SOFA scores during whole follow-up compared to those
patients with low BNP and high proteinuria. Intermedi-
ate SOFA scores were seen in the two other groups
(Figure 3).
Discussion
This is the first study which combines levels of BNP and
proteinuria in patients with severe burns to investigate
whether these clinical parameters could be used as mar-
kers of resuscitation and prognosis.
Rapid and aggressive fluid resuscitation is crucial in
patients with severe burn injury. However, no formula is
available yet which determines the exact burn victim’s
fluid requirements. Nowadays, the well known formulas
as the Parkland formula or the modified Brooke formula
are used. However, these only guide the initiation of
Figure 2 Total received fluid and SOFA scores in patients with high and low BNP. A. Received fluid, B. Sequential Organ Failure
Assessment (SOFA) scores. Dashed line presents patients with a high B-type Natriuretic Peptide (BNP), closed line patients with a low BNP.
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especially the amounts of fluid as calculated by the
Parkland formula is subject to discussion [17,18]. The
requirement of fluids of each individual patient, espe-
cially after the first 48 hours, is difficult to determine
with these formulas. Therefore, adjustments to esti-
mated fluid requirements must be made based upon a
patient’s physiologic response to resuscitation. Most
often urine production is used. Other clinical signs of
volume status, such as heart rate, blood pressure, capil-
lary refill, and colour of uninjured skin are also taken
into account. Specific laboratory measurements for ade-
quacy of resuscitation are mixed venous blood gas and
lactate. Invasive monitoring such as central venous pres-
sure may also be useful for monitoring fluid resuscita-
tion, but is invasive, has an increased risk of infection
and is not always available. Despite all these different
markers, it still remains very difficult to determine the
optimal amount of fluid in each individual patient in
clinical practice. BNP is an interesting marker of fluid
resuscitation as it is secreted from the myocardium
under increased wall stretch. BNP is nowadays used in
the diagnosis of heart failure [5-8]. We investigated
whether BNP levels can be used to monitor fluid bal-
ance in patients with severe burns. We hypothesize that
in case of resuscitation and no loss of fluid into the
third space, BNP levels increase. Indeed, in a few studies
with a small number of patients increasing levels of
BNP have been demonstrated during resuscitation [3,4].
In our study BNP levels increased during the follow-up,
especially during the first three days of resuscitation in
which the highest amounts of fluid were administered.
Those patients who received a smaller amount of fluids,
and thus were hemodynamically stable since the amount
of fluids was determined based on adequate urine pro-
duction and blood pressure, had increased BNP levels.
Probably, these higher levels of BNP reflect fluid distri-
bution to be more present in the intravascular compart-
ment due to less capillary leakage. Furthermore, the
finding that BNP levels were lower in patients with
inhalation injury, who frequently require larger than
predicted fluid resuscitation volumes, supports the
hypothesis that low BNP levels may be due to more
severe injury and increased fluid needs, which are not
being met during resuscitation. To translate this into
clinical practice, this might support higher resuscitation
volumes in burn patients with inhalation injury com-
pared to patients without inhalation injury.
Several factors are known to correlate with BNP, such
as age, gender, renal function and cardiac history. In
this study, BNP levels were not influenced by renal
function, since in most patients renal function remained
normal during follow-up and did not correlate with
BNP (creatinine clearance Day 3 vs BNP level Day 3, r
= -0.23, P = 0.27). Furthermore, only five patients had a
cardiac history. These patients were equally divided
between the groups and did not influence BNP levels.
No correlation was found between gender and levels of
Table 2 Characteristics of the different groups divided based on median BNP and median proteinuria
High BNP, low prot (n =
7)
Low BNP, low prot (n =
12)
High BNP, high prot (n =
12)
Low BNP, high prot (n =
7)
Age, years 43 (35 to 63) 55 (31 to 63) 48 (39 to 61) 38 (37 to 46)
Male, n (%) 5 (71%) 8 (75%) 8 (75%) 7 (100%)
Weight, kg 70 (70 to 100) 91 (78 to 117) 87 (76 to 97) 90 (76 to 100)
TBSA > 20%, n (%) 6 (86%) 10 (83%) 10 (83%) 7 (100%)
Inhalation, n (%) 2 (29%) 6 (50%) 7 (58%) 6 (86%)
TBSA, % 28 (25 to 45) 31 (21 to 40) 32 (20 to 43) 37 (30 to 45)
Creatinin clearance, ml/
min
95 (80 to 148) 148 (116 to 188) 122 (81 to 200) 156 (131 to 206)
Dead, n (%) 0 1 (8%) 3 (25%) 0
SOFA at Day 20 0 (0 to 1) 0 (0 to 3) 1 (0 to 3.5) 3 (1 to 4)
Data are presented by median (interquartile range)
(Inhalation: P likelihood P = 0.157, lineair P = 0.03)
SOFA, sequential organ failure assessment; TBSA, total burned body surface area
Figure 3 SOFA scores in groups of patients divided based on
median BNP and median proteinuria.
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Page 5 of 8BNP, in contrast to what is described in the literature
[19]. A possible explanation, besides the rather small
patient group, is the fact that hyperdynamic circulation
and changed fluid status influence levels of BNP more
than renal function, history of cardiac disease or gender
in patients with severe burns. Increased BNP levels have
been described in septic patients, which is caused by
several factors; for example, inflammation, myocardial
dysfunction, severity of global tissue hypoxia, fluid man-
agement, vasoactive drugs and renal dysfunction [7,20].
Of course, it is interesting to evaluate whether our
patients with high BNP levels had an increased cardiac
output state compared to those with low BNP levels. As
no invasive measurements were available, heart rate was
used as a marker of a hyperdynamic state. No correla-
tion was found between levels of BNP at Day 3 with
heart rate at Day 3 (r = -0.20, P = 0.27), indicating that
other variables, including fluid status, might influence
levels of BNP even more.
BNP has been shown to be prognostically negative in
the intensive care population and has been called the
death hormone [21]. However, predicting mortality in
the intensive care unit has been inconsistent, with sev-
eral studies showing that BNP levels correlate with mor-
tality and others that do not [20-23]. Many conditions
and therapies common in intensive care patients can
affect BNP levels. Also, there is a high variability in the
characteristics of intensive care patients enrolled in
these studies. It might be hypothesized that in burn
patients the worst outcome is correlated with extensive
capillary leakage, which is reflected by low BNP levels
despite a high amount of fluid resuscitation.
Proteinuria is an interesting marker of survival in criti-
cal ill patients [13,14]. In this study, patients with higher
average proteinuria at Days 1 and 2 have higher SOFA
scores reflecting a worse outcome. Moreover, a trend
was found between proteinuria and inhalation injury. In
the literature, there are conflicting data on the associa-
tion between outcome and microalbuminuria in patients
with severe burns. Yew et al. [24] concluded that micro-
albuminuria is a strong predictor of mortality; a more
recent study did not find a correlation between microal-
b u m i n u r i aa n do u t c o m ei nb u r ni n j u r y[ 2 5 ] .A tt h i s
point, it is not known whether proteinuria or microalbu-
minuria is a better prognostic marker or what the best
interpretation would be. We decided to use proteinuria,
as Sviridov et al. proposed, instead of albuminuria in
patients with severe burns, since the composition of
urinary proteins is disturbed and unusual after burn
injury [26]. In future studies it would be interesting to
include proteinuria as well as albuminuria.
Proteinuria and, especially, microalbuminuria have
been described as markers of endothelial dysfunction
c.q. systemic capillary leakage [10,11,27,28]. As
capillary leakage influences the individual need of
resuscitation, it would be very interesting to combine
BNP and proteinuria. It could be hypothesized that
patients with high proteinuria have more capillary
leakage, and thus no increase in BNP levels. Indeed,
this study showed that patients with low BNP and high
proteinuria performed worse than patients with high
BNP and low proteinuria.
This study has some limitations. A rather small num-
ber of patients was included. Furthermore, there were
missing data; for example, when patients had good clini-
cal conditions fewer laboratory measurements were per-
formed, resulting in difficulties in calculating SOFA
scores. Interpolated values were used based on the most
recent and subsequently recorded values to prevent bias.
Otherwise calculation of SOFA-scores would only have
been possible for patients who were in poor condition.
Concerning the measurement of proteinuria, many
variables, which were not included, are known to influ-
ence proteinuria, (for example, fever and use of amino-
glycosides). It would be interesting to include these
variables in future investigations. No laboratory mea-
surements, such as of lactate or invasive measurements,
were determined to confirm that BNP levels reflect the
hemodynamic situation of the patient. In larger cardiac
studies, BNP generally correlates with cardiac function
[29]. Furthermore, levels of BNP have been demon-
strated to correlate to mean pulmonary capillary wedge
pressure as an indicator of left ventricular end-diastolic
pressure in patients with acute dyspnoea [8]. However,
in a more general intensive care population the correla-
tion between BNP and invasive measurements is rather
poor [30]. Also, Papp et al. did measure BNP and inva-
sive measurements in nine burn patients, and no asso-
ciations were found [4]. On the other hand, the
association of a high BNP and the lower received fluid
volume found in this study suggests that BNP can be
used as a tool along with other clinical markers, includ-
ing urine production and blood pressure, in the indivi-
dual patient to adjust fluid orders to actual demands.
Further research should be performed to confirm this
hypothesis.
Conclusions
Nowadays, in clinical practice the amount of resuscita-
tion fluids in burn patients are calculated by formulas
such as the Parkland formula, which is based on weight
and TBSA. After the first 24 hours (or 48 hours) the
amount of fluid is adjusted most often based on clinical
parameters, such as urine production, blood pressure
and heart rate. We propose that a combination of BNP
levels and proteinuria might be used to individualize the
administration of the amounts of fluid and to predict
outcome in patients with severe burns.
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￿ It is difficult to adjust fluid balance adequately in
patients with severe burns due to various physical
changes.
￿ B-type Natriuretic Peptide (BNP) is emerging as a
potential marker of hydration state and might be
used to individualize the administration of the
amounts of fluid in patients with severe burns.
￿ Proteinuria might reflect systemic capillary leakage
and is also associated with illness severity and mor-
tality on the intensive care unit.
￿ In combination with low proteinuria, possibly
reflecting minimal capillary leakage, a high BNP
level was associated with a better outcome.
￿ Thus, BNP and proteinuria might have prognostic
potential in severely burned patients.
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